REPLIGEN NAMES VP'SRepligen Corp. of Cambridge, Mass., last week announced thatJames R, Rusche has been promoted to vice president. Ruscheretains his position as the company's director ofimmunotherapy. Repligen also named Ramesh L. Ratan to thenew position of senior vice president of administration. Ratanwill continue as the company's chief financial officer.
GENOSYS PICKS PRESIDENT
Genosys Biotechnologies Inc. of The Woodlands, Texas, onFriday said it has named Ralph Weaver its president and chiefexecutive officer.
Genosys manufactures synthetic DNA segments forbiotechnology research. Weaver is also senior vice presidentand chief financial officer of OmniMed Corp., a Houston-basedventure investment and management company, which lastOctober purchased a controlling interest in Genosys.
ISIS APPOINTS EXECUTIVE VP
Isis Pharmaceuticals of San Diego last week named Daniel L.Kisner, former division vice president of pharmaceuticaldevelopment at Abbott Laboratories, executive vice presidentfocusing on business development.
(c) 1997 American Health Consultants. All rights reserved.